Cargando…

Identification of Ovarian Cancer Metastatic miRNAs

Serous epithelial ovarian cancer (EOC) patients often succumb to aggressive metastatic disease, yet little is known about the behavior and genetics of ovarian cancer metastasis. Here, we aim to understand how omental metastases differ from primary tumors and how these differences may influence chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vang, Souriya, Wu, Hsin-Ta, Fischer, Andrew, Miller, Daniel H., MacLaughlan, Shannon, Douglass, Elijah, Steinhoff, Margaret, Collins, Colin, Smith, Peter J. S., Brard, Laurent, Brodsky, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595263/ https://www.ncbi.nlm.nih.gov/pubmed/23554878 http://dx.doi.org/10.1371/journal.pone.0058226

Ejemplares similares

Correction: Identification of Ovarian Cancer Metastatic miRNAs
por: Vang, Souriya, et al.
Publicado: (2014)

Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease
por: Brodsky, Alexander S., et al.
Publicado: (2014)

Leadership aspirations among residents in obstetrics and gynecology in the United States: a cross-sectional analysis
por: Bavan, Brindha, et al.
Publicado: (2019)

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
por: Stuckey, Ashley, et al.
Publicado: (2011)

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
por: Moore, Richard G., et al.
Publicado: (2014)

Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
por: Ayyagari, Vijayalakshmi N, et al.
Publicado: (2014)

Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study
por: MacLaughlan David, Shannon, et al.
Publicado: (2013)

Role of miRNAs interference on ovarian functions and premature ovarian failure
por: Nouri, Narjes, et al.
Publicado: (2022)

Increased Local Testosterone Levels Alter Human Fallopian Tube mRNA Profile and Signaling
por: Russo, Angela, et al.
Publicado: (2023)

Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
por: Alfaro, Ignacio, et al.
Publicado: (2023)

Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells
por: Kim, Kyu Kwang, et al.
Publicado: (2010)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

The clinical impact of intra‐ and extracellular miRNAs in ovarian cancer
por: Yoshida, Kosuke, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer
por: Xiong, Jun, et al.
Publicado: (2023)

The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer
por: Nakamura, Natsuho, et al.
Publicado: (2020)

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
por: Bowden, Michaela, et al.
Publicado: (2017)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
por: Du, Meijun, et al.
Publicado: (2017)

Identification of miRNAs during mouse postnatal ovarian development and superovulation
por: Khan, Hamid Ali, et al.
Publicado: (2015)

A combination of circulating miRNAs for the early detection of ovarian cancer
por: Yokoi, Akira, et al.
Publicado: (2017)

Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer
por: Dogan, Berkcan, et al.
Publicado: (2022)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer
por: Wang, Wenwen, et al.
Publicado: (2021)

Comprehensive analysis of mRNAs and miRNAs in the ovarian follicles of uniparous and multiple goats at estrus phase
por: Zou, Xian, et al.
Publicado: (2020)

The intestinal microbiota influences the microenvironment of metastatic colon cancer by targeting miRNAs
por: Zhou, Shihai, et al.
Publicado: (2022)

Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Comprehensive analysis on diagnostic value of circulating miRNAs for patients with ovarian cancer
por: Wang, Huiqing, et al.
Publicado: (2017)

Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2018)

Circulating miRNAs as Biomarkers for Endometriosis and Endometriosis-Related Ovarian Cancer—An Overview
por: Moga, Marius Alexandru, et al.
Publicado: (2019)

Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer
por: Retamales-Ortega, Rocío, et al.
Publicado: (2017)

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
por: Patel, Monal, et al.
Publicado: (2021)

Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
por: Kumar, Vivek, et al.
Publicado: (2021)

Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression—An in vitro study
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2020)

Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis
por: Wu, Richard Licheng, et al.
Publicado: (2015)

Ovarian transcriptomic study reveals the differential regulation of miRNAs and lncRNAs related to fecundity in different sheep
por: Miao, Xiangyang, et al.
Publicado: (2016)

Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rt0a5nad0270bmd7g80t9vectk